Skip to content

Clinical trials

Completed Hypertension, Pulmonary trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Status: Completed Country / region: France Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20031
20041
20055
20062
20072
20084
20096
20102
20113
20121
20146
20151
20162
20172
20181
20195
20217
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer9
Assistance Publique - Hôpitaux de Paris7
United Therapeutics6
University Hospital, Bordeaux4
Central Hospital, Nancy, France3
Eli Lilly and Company3
GlaxoSmithKline3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Actelion2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary59
Pulmonary Arterial Hypertension17
Familial Primary Pulmonary Hypertension4
Pulmonary Disease, Chronic Obstructive4
Hypertension3
Lung Diseases2
Anxiety Disorders1
Bone Diseases1
Bronchiolitis1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.